Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Abatacept in B7-1–Positive Proteinuric Kidney Disease
Ist Teil von
The New England journal of medicine, 2014-03, Vol.370 (13), p.1261-1266
Ort / Verlag
United States: Massachusetts Medical Society
Erscheinungsjahr
2014
Link zum Volltext
Quelle
Free E-Journal (出版社公開部分のみ)
Beschreibungen/Notizen
To the Editor:
In their Brief Report, Yu et al. (Dec. 19 issue)
1
describe the use of abatacept, an inhibitor of the T-cell costimulatory molecule B7-1, in inducing remission in five patients with focal segmental glomerulosclerosis (FSGS) resistant to rituximab and glucocorticoids (one patient with primary FSGS and four with recurrent FSGS after transplantation). The rationale for using abatacept was that B7-1 is induced in podocytes in primary and recurrent FSGS as well as in patients with membranous nephropathy.
In an attempt to reproduce their findings with the same antibodies, we found no B7-1 signal in samples obtained from patients . . .